🇺🇸 FDA

Company profile · Sponsor

Jian

Jian Li

CF0D965 · NMPA pharma CN
Pipeline
24
Drugs
0
Patents
0

Quick answer

Jian (CF0D965) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 24 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker CF0D965
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (24)

Search pipeline →

  1. HS-20094 Injection

    Jian

    Type 2 Diabetes

    phase 3 small molecule active

    1 trial

  2. Irinotecan liposome、5-Fluorouracil、Leucovorin

    Jian

    Second-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer After Treatment Failure With Gemcitabine-based Therapy

    phase 3 small molecule completed

    1 trial

  3. Placebos

    Jian

    Advanced Non-small Cell Lung Cancer

    phase 3 small molecule completed

    1 trial

  4. SHR-1210

    Jian

    Locally Advanced or Metastatic and Unresectable HCC

    phase 3 small molecule completed

    1 trial

  5. HRS-6213

    Jian

    Patients With Solid Tumors

    phase 2 small molecule active

    1 trial

  6. High-Low Dose Radiotherapy

    Jian

    Nasopharyngeal Carcinoma (NPC)

    phase 2 other active

    1 trial

  7. Karelizumab combined with etoposide and cisplatin

    Jian

    Carcinoma

    phase 2 small molecule active

    1 trial

  8. Part1:Recombinant two-component COVID-19 vaccine (CHO cell)

    Jian

    COVID-19

    phase 2 mab completed

    1 trial

  9. SHR20004

    Jian

    Obesity

    phase 2 small molecule active

    1 trial

  10. 626

    Jian

    Healthy Subjects (HS)

    phase 1 small molecule active

    1 trial

  11. 68Ga-FAPI-04

    Jian

    Fibrosis

    phase 1 small molecule active

    1 trial

  12. APL-1202 and APL-1501 (Single ascending dose)

    Jian

    Bladder Cancer

    phase 1 small molecule active

    1 trial

  13. Ad5-EBOV

    Jian

    Ebola Virus Disease

    phase 1 mab completed

    1 trial

  14. Daridorexant

    Jian

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  15. GST-HG121 tablets

    Jian

    Pharmacokinetics

    phase 1 small molecule active

    1 trial

  16. HRS-2329 Tablet

    Jian

    Advanced Solid Tumors Harboring RAS Mutations or Amplifications

    phase 1 small molecule active

    1 trial

  17. HS-10345 84mg

    Jian

    Treatment Resistant Depressive Disorder

    phase 1 small molecule completed

    1 trial

  18. HS-10382(Part 1: Dose escalation)

    Jian

    CML, Chronic Phase

    phase 1 small molecule active

    1 trial

  19. Nemonoxacin

    Jian

    Kidney Dysfunction

    phase 1 small molecule active

    1 trial

  20. SHR-1501

    Jian

    Advanced Malignancies

    phase 1 small molecule completed

    1 trial

  21. SHR1459 tablet

    Jian

    B-cell Tumors

    phase 1 small molecule completed

    1 trial

  22. SHR2554 and Itraconazole

    Jian

    Healthy Adult Subjects

    phase 1 small molecule completed

    1 trial

  23. [14C] HRS-9190

    Jian

    Healthy Adult Male

    phase 1 small molecule active

    1 trial

  24. Bupivacaine Liposome Injection

    Jian

    Local Analgesia Via Infiltration

    approved small molecule active

    1 trial

Frequently asked questions

What is Jian?

Jian (CF0D965) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 24 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Jian sponsor?

We track 24 ClinicalTrials.gov-linked programs for Jian, including HS-20094 Injection and 23 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Jian company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.